NCT03393741 2024-06-25
Pharmacodynamic Biomarkers of Standard Anti-microtubule Drugs as Assessed by Early Tumor Biopsy
University of Wisconsin, Madison
Terminated
Clinical Trials
9 trialsNCT05912062 2023-09-29
BiOnHER
Institut Català d'Oncologia
Unknown
NCT05128617 2023-06-08
PROTECT-06
Institut de cancérologie Strasbourg Europe
Completed
NCT05580887 2022-10-14
Intestinal Microbiota Impact for Prognosis and Treatment Outcomes in Early Luminal Breast Cancer and Pancreatic Cancer Patients
Moscow Clinical Scientific Center
Unknown
NCT05131893 2021-11-23
Neoadjuvant Treatment of Breast Cancer
National Institute of Oncology, Hungary
Not yet recruiting
NCT00897026 2021-08-17
Studying Tissue Samples From Women Who Underwent Chemotherapy for Lymph Node-Positive Stage II or Stage IIIA Breast Cancer on Clinical Trial CLB-9741 or CLB-9344
Alliance for Clinical Trials in Oncology
Completed
NCT02613208 2020-02-17
Argo
Hoffmann-La Roche
Completed
NCT00537173 2017-01-25
Predicting Response and Toxicity in Patients Receiving Paclitaxel and Avastin for Breast Cancer
Hoosier Cancer Research Network
Terminated
NCT00131963 2016-07-25
A Pharmacogenomics Study for Breast Cancer Patients Undergoing Adjuvant Chemotherapy With Doxorubicin (A)/Cyclophosphamide ©) and/or Weekly Paclitaxel
Duke University
Completed